One of the primary benefits of tamoxifen is its ability to significantly reduce the risk of breast cancer recurrence and improve overall survival rates in individuals with ER+ breast cancer. Additionally, tamoxifen has been shown to reduce the risk of cancer spreading to other parts of the body (metastasis).
